#United States #Los Angeles #Cannabis #KANHA #Sunderstorm

Sunderstorm Takes KANHA Global: A Strategic Move in Cannabis

Sunderstorm, headquartered in California, is a prominent player in the premium cannabis sector, known for its popular KANHA brand. The company has recently announced a significant growth initiative aimed at expanding its international footprint through strategic partnerships. This move marks an important phase in Sunderstorm's comprehensive plan to enter the burgeoning medical-grade cannabis markets across Europe and Australia.

A Strategic Partnership

The latest developments saw Sunderstorm joining forces with New Garden Pharma, a licensed manufacturer operating out of North Macedonia. This collaboration will enable Sunderstorm to leverage EU-GMP standards for producing pharmaceutical-grade cannabis edibles that will be distributed in Europe and Australia. In addition to this partnership, Sunderstorm is collaborating with other key players such as California’s Medical GmbH in Germany, FuGu Holdings in Australia, and Grow Group UK in the UK. Together, these alliances are constructed to solidify KANHA's presence in new markets while ensuring compliance with the rigorous standards required in the medical cannabis industry.

KANHA: A Leading Brand

For the past decade, the KANHA brand has enjoyed status as a top seller in the U.S. cannabis market. Sunderstorm laid the groundwork for its international expansion strategy three years ago by moving into Thailand. KANHA has since gained a foothold in crucial markets and continues to build its reputation by distributing high-quality medical cannabis products globally.

Through the established EU-GMP facility in Skopje, Sunderstorm will produce not only edibles but also develop new product formats that align with consumer needs. These initiatives highlight Sunderstorm's commitment to maintaining the quality, consistency, and precision KANHA consumers have come to expect, regardless of geographical boundaries.

A Fast-Growing Market

The medical cannabis markets in Europe and Asia-Pacific are among the fastest-growing in the world. As the market value in Europe is projected to escalate from approximately $3 billion in 2025 to an astounding $13.16 billion by 2034, Sunderstorm is well-positioned to tap into this expanding demand. Similarly, the Asia-Pacific region is expected to see its medical market grow from $630 million to $2.63 billion by 2033. With an established distribution network, particularly in regions such as the UK and Germany, KANHA is ready to meet the needs of both patients and wellness consumers in an era of increasing international acceptance of medical cannabis.

Leadership Commitment

Cameron Clarke, Co-founder and CEO of Sunderstorm, expressed excitement about this global venture, emphasizing how KANHA is poised to become one of the first truly global cannabis brands. According to him, their decade-long effort to establish KANHA in the U.S. has now set the stage for a fully integrated international supply chain allowing Sunderstorm to deliver pharmaceutical-grade products that comply with stringent global standards.

In collaboration with New Garden Pharma, Clarke notes that their phase of expanding reliable and accessible cannabis products is not just about reaching markets but also about ensuring patients gain access to safe, precisely formulated options that add value to their health.

Quality Assurance

The strategic partnership with New Garden Pharma is positioning KANHA at the forefront of medical cannabis innovation. Alexey Brylev, CEO of New Garden Group, believes this collaboration will create a new benchmark for quality and innovation. By combining their EU-GMP certified infrastructure with Sunderstorm's strong brand identity, they’re unlocking new avenues for customer service in the international cannabis framework.

KANHA has built its foundation on delivering clean, high-quality formulations recognized for their fast-acting effects and precise dosing. As the company continues to expand globally, each step taken to introduce KANHA’s offerings to new markets reinforces its commitment to quality and reliability.

With already established operational bases in Thailand and strategic partnerships paving the way for its products in Europe and Australia, KANHA is on track to meet the demands of an evolving international cannabis market, blending wellness with patient care seamlessly.

About Sunderstorm and its Partners

Founded in 2015, Sunderstorm is recognized for its innovative range of cannabis products and leads with brands like KANHA, known for its edibles and vapes. KANHA’s reputation stems from initiatives such as its Fresh Promise: ensuring zero pesticide use and strict quality assessments. As Sunderstorm opens doors to international markets through these partnerships and continuous innovation, the future for KANHA looks bright, embodying a commitment towards greater wellness across borders.

With its partners, including New Garden Pharma and Grow Group UK, the company promises to provide quality and access that reflects today’s escalating global demand for medical cannabis solutions.